BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc., has entered into an agreement to acquire certain assets ...
A new gruesome case of the rape and murder of a young female doctor trainee in India is bringing once again to the forefront ...
Cogent's optical wavelength services potential, solid dividend growth, and potential benefit from lower interest rates offer ...